Skip to main content

Table 4 Use of anti-osteoporosis drugs in the BMD <70 % of YAM and BMD ≥70 % of YAM groups

From: Risk of low bone mineral density in patients with rheumatoid arthritis treated with biologics

  BMD <70 % of YAM BMD ≥70 % of YAM
None 13 58
Anti-osteoporosis drug use (total) 44 71
  1. (p = 0.004)
  2. BMD bone mineral density, YAM young adult mean